Sort
64,565 grants matching “drug discovery”
High Throughput, Label-Fee Molecular Interaction Platform for Membrane Protein Ta
$1,260,614Scot Randy Weinberger · Molecular Sensing, Inc. · R44 · FY2011 · GM
AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning
$1,259,982Zhongming Zhao · University Of Texas Hlth Sci Ctr Houston · U01 · FY2025 · AG
The cBioPortal for Cancer Genomics
$1,259,920Nikolaus Schultz · Sloan-Kettering Inst Can Research · U24 · FY2018 · CA
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
$1,259,901Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2020 · AA
Response Therapies for MDR-TB
$1,259,826Ian M Orme · Colorado State University · U01 · FY2010 · AI
STRUCTURAL BIOLOGY AND TARGETED DRUG DESIGN FOR AIDS
$1,259,788University Of California San Francisco · P01 · FY2000 · GM
University of Texas PDX Development and Trial Center
$1,259,703Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2021 · CA
NATURAL INHIBITORS OF CARCINOGENESIS
$1,258,800University Of Illinois At Chicago · P01 · FY2001 · CA
Vascular remodeling in patients with rare genetic disorders
$1,258,692Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,258,277Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Cancer Center Support Grant
$1,258,258Timothy L Ratliff · Purdue University · P30 · FY2010 · CA
Human Genes Affecting Chromosome Metabolism and Stress Response
$1,257,687Daniel Menendez · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Human iPSC neural spheroids to screen for compounds that block tau propagation
$1,257,528Travis Lee Stiles · Novoron Bioscience, Inc. · R44 · FY2025 · AG
KOR Phase 1- FAST MAS (HHSN271201200006I) award-Duke Univ
$1,257,492Rose Hood · Duke University · N01 · FY2013 · DA
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
$1,257,364Deborah T Hung · Broad Institute, Inc. · U19 · FY2023 · AI
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
$1,257,243Matthew G Dorsey · University Of California, San Francisco · U19 · FY2019 · AI
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,256,218Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · AI
Delivery of biologically active nucleic acids to epidermal cells
$1,256,097Roger L Kaspar · Transderm, Inc. · RC2 · FY2010 · AR
STRUCTURE-BASED DESIGN PARADIGM:HIV Tat.PCAF INHIBITORS
$1,255,985Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · P01 · FY2006 · GM
Characterizing the AD Metabolome in Brain Tissue Samples of Individuals from Diverse Populations
$1,255,605Rima F Kaddurah-Daouk · Duke University · U01 · FY2022 · AG
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,255,285Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2015 · AI
A High Content Screening Platform for High Throughput, High Content Imaging and Analysis
$1,254,909Patricia Helen McDonald · H. Lee Moffitt Cancer Ctr & Res Inst · S10 · FY2022 · OD
Center for Interventional Oncology
$1,254,568Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2022 · CA
Novel Approaches for Tau PROTAC Drug Discovery
$1,254,536Karteek Kadimisetty · Lifesensors, Inc. · R44 · FY2023 · AG
Therapeutic targets and novel anticancer agents for endocrine cancers
$1,254,239Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA